Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?

Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?

Submitted by admin on July 19, 2021 - 10:52am
Source: 
Motley Fool
News Tags: 
Moderna Therapeutics
Alexion
S&P 500
vaccines
COVID-19
Headline: 
Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?
snippet: 
  • Moderna is replacing Alexion Pharmaceuticals on the S&P 500 index.
  • The performances of stocks that have recently been added to the index don't help much in determining how Moderna's shares will perform.
  • The most important thing for Moderna right now is what happens with coronavirus variants of concern.

Do Not Allow Advertisers to Use My Personal information